Immune checkpoint blockades, or ICBs, have revolutionized treatment for various advanced cancers. However, their effectiveness has plateaued due to therapeutic resistance that renders ...
What are the implications? Our study demonstrates that combining anti-CXCR4 and anti-PD1 is more effective than anti-PD1 alone in mouse models of liver cancer and that the increased dendritic cell ...
Researchers are shining a light on cancer cells' energy centers -- literally -- to damage these power sources and trigger widespread cancer cell death. In a new study, scientists combined strategies ...